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1015-9584/Copyright ª 2015, Asian SuSummary Background/Objective: To determine the quality of life (QoL) in Thais after inter-
vention for great saphenous vein (GSV) reflux.
Methods: Patients with Clinical Etiologic Anatomic Pathophysiologic classes 2 and 3 were
enrolled in this study. QoL was measured using the EuroQol descriptive system (EQ-5D) ques-
tionnaire, and patients chose to receive either endovenous treatment or surgery after consul-
ting with their surgeons. The QoL before the intervention, at 1 week, and at 1 month after the
intervention were evaluated. Patients who reported “no problem” in each domain of the EQ-5D
questionnaire before and 1 month after the intervention were compared. Utility gain was esti-
mated from the questionnaire and compared between clinical classes. The proportion of wors-
ening QoL at 1 week after the intervention was compared between patients receiving
endovenous procedures and surgery.ng authors declare no conflicts of interest.
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great saphenous vein reflux, Asian JoResults: A total of 83 patientsd56 received endovenous procedures [23 received ultrasound-
guided foam sclerotherapy (UGFS) and 33 received radiofrequency ablation (RFA)] and 27
received surgerydwere enrolled. QoLs were significantly better in all domains after the inter-
vention: pain/discomfort (58%), mobility (42%), anxiety/depression (38%), usual activities
(19%), and self-care (9%). Utility gain was 0.255 (95% confidence interval: 0.197e0.313) and
higher in class 3. At 1 week after the intervention, surgery had significantly higher patients
with worse mobility scores. Among endovenous procedures, UGFS had higher patients with
worse pain/discomfort scores than RFA at 1 week after the intervention (16% vs. 0%,
p Z 0.025).
Conclusion: GSV ablation for GSV reflux in Thai patients with CEAP C2 and C3 categories signif-
icantly improves both physical and mental QoL; patients who received endovenous procedures
were found to have better early physical QoL.
Copyright ª 2015, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Varicose veins are common with prevalence rates of
10e15% in men and 20e25% in women1 with an increasing
prevalence with advancing age.2 This has led to significant
health spending.3 The great saphenous vein (GSV) is the
most common site of venous reflux and the standard
treatment is ablation of this vein. Important outcomes after
GSV ablation are anatomical occlusion, abolishment of
reflux in the treated vein, good function, and good quality
of life (QoL) for treated patients.4
Assessing patient’s QoL is important in patient-centered
approach because QoL measures patient’s perceptions and
concerns. QoL is also used for estimating utility scores,
which are used to estimate quality-adjusted life years
gained for health technology assessments to determine cost
effectiveness of interventions.5e7 Data from European
countries have demonstrated improvement in patient’s QoL
using both generic8,9 and disease-specific QoL question-
naires10,11 after GSV ablation for GSV incompetence in pa-
tients with simple varicose veins and more severe disease
such as lipodermatosclerosis and venous ulceration.
Recent guidelines recommend endovenous thermal
ablation over open surgery because endovenous ablation is
associated with less pain and morbidity with shorter times
to recovery.4 In terms of post-treatment QoL, a recent
systematic review and meta-analysis12 found better QoL at
1e2 weeks in favor of endovenous procedures over surgery
but QoL thereafter was similar.
GSV-related QoL data in Asians are limited and there are
no data from Thailand. Currently, all patients with GSV
reflux treated by standard surgery and ultrasound-guided
foam sclerotherapy (UGFS) are reimbursable by the Thai
health care system irrespective of the Clinical Etiologic
Anatomic Pathophysiologic (CEAP) clinical class and symp-
toms; however, those treated by radiofrequency ablation
(RFA) are not eligible for reimbursement. A previous cost
analysis for health economic evaluation in Thailand indi-
cated that RFA had procedure-related costs of 26,417 Thai
Baht, compared with 5556 Thai Baht and 5096 Thai Baht for
UGFS and surgery, respectively.13 Treatment for patients in
CEAP clinical classes 4e6 clearly demonstrated significantiribumrungwong B, et al., Quality
urnal of Surgery (2015), http://dQoL gain,14 but treatment benefit in patients with less se-
vere disease (clinical classes 2 or 3) was still questionable.
Therefore, this study was conducted to determine QoL
after intervention in CEAP clinical classes 2 and 3 patients
with GSV reflux who seek medical attention in Thailand and
also compared QoL after endovenous procedures and
surgery.
2. Methods
The study was conducted at two university hospitals
(Thammasat University Hospital, Pathum Thani, Thailand
and Ramathibodi Hospital, Bangkok, Thailand) and one
provincial hospital (Chonburi Hospital, Chonburi, Thailand)
and was approved by the Ethics Committee Boards of all
three study hospitals. All patients were informed and
signed consents before the intervention. Patients were
treated by a general and vascular surgeon who had expe-
rience working in this area for 5 years. Eligible patients
were those with CEAP clinical classes 2 or 3 with a docu-
mented history of isolated unilateral GSV reflux, diagnosed
by duplex scan, who underwent any one of the these pro-
cedures: RFA, UGFS, or surgery (high ligation and striping).
The study was conducted between October 2011 and
February 2013. Exclusion criteria were any one of the
following: (1) history of deep vein thrombosis, (2) history of
superficial thrombophlebitis, (3) peripheral arterial occlu-
sive disease, and (4) pregnancy.
Consecutive patients who met the eligibility criteria and
treated at the clinics of the participating surgeons were
invited to participate in the study. The benefit and cost of
each intervention was explained to the patients by the
participating surgeons and then the patients were allowed
to select an intervention method. RFA (Covidien Closure-
Fast, San Jose, CA, USA) was performed with tumescent
anesthesia. The ablation was performed with incremental
steps of 7 cm starting from 2e3 cm distal to the sapheno-
femoral junction to the knee level. The UGFS was per-
formed concomitantly with saphenofemoral ligation by
injecting foam sclerosant (Tessari’s method; 1 cm3 of 1%
aethoxysklerol mixed with 3 cm3 of air) of about 6e8 cm3 to
the GSV just below the knee level. Surgery was performedof life after great saphenous vein ablation in Thai patients with
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the GSV just below the knee.
Baseline characteristics of patients including age, sex,
CEAP clinical classification, and venous clinical severity
scores (VCSSs) were collected on a standard case record
form. The QoL used was the generic EuroQol descriptive
system (EQ-5D) questionnaire. This self-administered
questionnaire has five domains, namely, mobility, self-
care, usual activities, pain/discomfort, and anxiety/
depression. Each domain was scored as follows: 1 (no
problem), 2 (some problems), or 3 (severe problems). The
questionnaire was administered to patients before the
intervention, at 1 week, and at 1 month after the inter-
vention. The translated (into Thai) version of the EQ-5D
questionnaire has already been validated and widely used
in Thailand.5 The health state preferences measured by the
EQ-5D questionnaire were then converted into utility scores
using the preference weight for the Thai population by
subtracting the relevant coefficients of results of each
domain from 1.0.5,15 A value close to 1.0 indicated “good
health” whereas a value close to 0 implied “worst health
condition.”
Baseline continuous data were described using mean
(SD) if they were normal distribution; otherwise, median
[interquartile range (IQR)] was used. Frequency and per-
centage were used to describe categorical data.
Changes in QoL over time were assessed by comparing
QoL score before and after the intervention. Changes were
then graded as worsening if the preintervention score was
higher than the postintervention score; otherwise, it was
graded as equal/better improvement. The proportion of
worsening QoL at 1 week after the intervention was then
estimated and compared between the intervention groups.
In addition, the proportion of patients reporting no problem
before and 1 month after the intervention was also
reported.
Changes in VCSS were calculated by subtracting pre-
intervention scores from postintervention scores, whereas
utility gain was calculated by subtracting postintervention
scores from preintervention scores. Data were then re-
ported using median (IQR).
Data were then compared between the intervention
groups as follows: one-way analysis of variance was applied
to compare means if data were normally distributed;
otherwise, KruskaleWallis test was applied to compareTable 1 Baseline characteristics between endovenous and surg
Variables RFA UGF
N Z 33 N Z
Age (y) 55 (9.9)
Income/mo, Thai Baht 30,000 (20,000e41,000) 10,4
GSV diameter (cm) 0.79 (0.14) 0.
CEAP C classification
C2 11 (35)
C3 20 (65)
VCSS 6 (5e7)
Data are presented as n (%), mean (standard deviation), or median (i
CEAP Z Clinical Etiologic Anatomic Pathophysiologic; GSV Z
UGFS Z ultrasound-guided foam sclerotherapy; VCSS Z Venous Clini
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compare proportions between the intervention groups.
McNemar’s Chi-square test was used to compare the pro-
portion of patients reporting “no problem” before and after
the intervention (using preintervention and post-
intervention scores). A p value <0.05 was considered to be
statistically significant. Analysis was performed using STATA
version 13.0 (StataCorp, College Station, TX, USA).3. Results
Eighty-three patients were enrolled. All completed the
preintervention questionnaires. Seventy-six (92%) and 64
(77%) completed postoperative questionnaires at 1 week
and 1 month, respectively. Among the 83 patients, 56 (67%)
had undergone endovenous procedures (i.e., 23 UGFS and
33 RFA) and 27 (33%) had received open surgery. Baseline
characteristics of the patients were evaluated and they
were not statistically different between the three groups,
except income/mo, which was higher in the RFA group than
in the other two groups (Table 1). The proportion of CEAP
classification C3 was highest in the open surgery (81%)
group, compared with the RFA (65%) and UGFS (53%) groups.
The VCSS was not significantly different (p Z 0.442) be-
tween the two groups with median values of 6, 5, and 6 for
RFA, UGFS, and surgery, respectively. In addition, pre-
intervention EQ-5D questionnaire responses were not
significantly different between endovenous procedures and
surgery (Table 2).3.1. QoL changes3.1.1. Preintervention versus 1-month postintervention
changes
The proportion of all patients who reported “no problem”
was significantly higher in all five domains after the inter-
vention, compared with that before the intervention
(Figure 1). Fifty-eight percent of patients had better QoL in
the pain/discomfort domain, followed by mobility (42%),
anxiety/depression (38%), usual activities (19%), and self-
care (9%) after the intervention.ery groups.
S Surgery p
23 N Z 27
49 (13.4) 52 (14.8) 0.25
80 (8000e20,000) 10,000 (3500e15,000) <0.001
69 (0.22) 0.85 (0.36) 0.39
0.12
9 (47) 5 (19)
10 (53) 22 (81)
5 (3e6) 6 (4e8) 0.44
nterquartile range).
greater saphenous vein; RFA Z radiofrequency ablation;
cal Severity Scores.
of life after great saphenous vein ablation in Thai patients with
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Table 2 Comparison of preintervention EQ-5D between
endovenous procedures and surgery.
EQ-5D Endovenous
procedures
n Z 54
Surgery
n Z 27
p
Mobility
No problem 27 (50) 10 (37) 0.35
Some problems 27 (50) 17 (63)
Severe
problems
0 (0) 0 (0)
Self-care
No problem 48 (89) 22 (81) 0.49
Some problems 6 (11) 5 (19)
Severe
problems
0 (0) 0 (0)
Usual activities
No problem 39 (72) 21 (78) 0.63
Some problems 14 (26) 5 (19)
Severe
problems
1 (2) 1 (4)
Pain/discomfort
No problem 14 (26) 7 (26) 0.94
Some problems 34 (63) 16 (59)
Severe
problems
6 (11) 4 (15)
Anxiety/depression
No problem 27 (50) 17 (63) 0.57
Some problems 24 (44) 9 (33)
Severe
problems
3 (6) 1 (4)
Data are presented as n (%).
EQ-5D Z EuroQol descriptive system.
Figure 1 Comparison of patient reporting no problems in each do
preintervention and at 1 month postintervention. The Y axis show
domains. The p values were obtained using McNemar’s chi-square
4 B. Siribumrungwong et al.
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After receiving intervention, mobility was significantly
worse in the surgical group compared with the endovenous
groups (i.e., 22% vs. 6%, p Z 0.038) at 1 week after the
intervention. There were no significant differences in the
other four domains (Table 3). Among endovenous in-
terventions, only pain/discomfort was significantly worse in
patients who received UGFS compared those who received
RFA (16% vs. 0%, p Z 0.025) at 1 week after the interven-
tion. The others were not significantly different at both 1
week and 1 month after the intervention (data not shown).3.2. VCSS, utility gain, and time to return to work
Health utility scores were, respectively, 0.617 and 0.888
before and after the intervention at 1 month in all patients,
yielding significant utility gain of 0.255 [95% confidence
interval (CI): 0.197e0.313]. The utility gain was also
significantly higher in the CEAP C3 category than in the C2
categoryd0.319 (95% CI: 0.254e0.386) versus 0.122 (95%
CI: 0.025e0.219), respectively (p Z 0.001). Among endo-
venous procedures, the health utility scores were 0.629 and
0.874 before and 1 month after the intervention, which
yielded utility gain of 0.225 (95% CI: 0.154e0.296).
Changes in VCSS for individual patients were calculated
by subtracting preintervention VCSS from postintervention
VCSS at each time (i.e., 1 week and 1 month). The change
was then averaged and compared across the three inter-
vention groups (Table 4). Although the mean VCSS change
was higher in the RFA and UGFS groups than in the open
surgery group for both periods, it was not statically
different. Seven (21%), three (13%), and five (19%) patients
who received RFA, UGFS, and surgery, respectively, did not
gain utility postoperatively at 1 month (p Z 0.73). Median
times to return to work were 2.5 day (IQR 2e4), 1 day (IQR
1e5), and 5 day (IQR 3e8.5) for RFA, UGFS, and surgery,main of the EuroQol descriptive system (EQ-5D) questionnaires
s the proportion of patients (%); the X axis shows the EQ-5D
test.
of life after great saphenous vein ablation in Thai patients with
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Table 3 Comparison of EQ-5D at 1 week and 1 month postinterventions between endovenous procedures and surgery.
EQ-5D 1 wk Postintervention 1-mo Postintervention
Endovenous procedures
n Z 49
Surgery
n Z 27
p Endovenous procedures
n Z 40
Surgery
n Z 24
p
Mobility
Better or equal 46 (94) 21 (78) 0.038 39 (98) 24 (100) >0.99
Worse 3 (6) 6 (22) 1 (2) 0 (0)
Self-care
Better or equal 40 (82) 17 (63) 0.072 40 (100) 24 (100) d
Worse 9 (18) 10 (37) 0 (0) 0 (0)
Usual activities
Better or equal 42 (86) 19 (70) 0.108 38 (95) 23 (96) >0.99
Worse 7 (14) 8 (30) 2 (5) 1 (4)
Pain/discomfort
Better or equal 46 (94) 24 (89) 0.440 36 (90) 23 (96) 0.64
Worse 3 (6) 3 (11) 4 (10) 1 (4)
Anxiety/depression
Better or equal 43 (88) 26 (96) 0.410 39 (98) 24 (100) >0.99
Worse 6 (12) 1 (4) 1 (2) 0 (0)
Data are presented as n (%).
QoL after varicose vein treatment in Thai 5
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compared with surgery (p Z 0.02).
4. Discussion
Our results demonstrate significant improvement in QoL in
all five domains of the EQ-5D questionnaires after treat-
ment in Thai patients with GSV reflux. Significant
improvement was seen in the “pain/discomfort” domain
followed by improvement in the mobility, anxiety/depres-
sion, usual activities, and self-care domains in descending
order. Utility gain was significantly better after interven-
tion in the CEAP category C3 than C2. Patients in the
endovenous groups had better QoL in the mobility domain
than those who received surgery at 1 week after the
respective procedures.
Our results were similar to those reported by Nesbitt
et al9 who also used the EQ-5D questionnaire and also with
studies that measured QoL using other type of question-
naires (i.e., Short Form-36), which found improvements in
bodily pain, physical function,8 and mental health afterTable 4 Comparison of changes in Venous Clinical Severity Sco
Time measured
postintervention
Overall
n Z 83
RFA
n Z 33
At 1 wk
VCSS 3 (2e4) 3 (3e4)
Utility gain 0.12 (0.46e0.31) 0.18 (0e0.31)
At 1 mo
VCSS 4 (2.5e5) 4 (3e5)
Utility gain 0.27 (0.05e0.39) 0.23 (0e0.37)
Data are presented as median (interquartile range).
RFA Z radiofrequency ablation; UGFS Z ultrasound-guided foam scle
* Comparison between three types of intervention.
a Changes of VCSS Z VCSS at preintervention  VCSS at postinterve
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GSV reflux on both physical and mental QoL.
In our study, surgery had a significantly worse QoL score
in the mobility domain and showed a trend toward wors-
ening self-care compared with endovenous procedures at 1
week after the intervention. This probably explains why
patients in the endovenous groups can return to normal
activities and work faster than those who received sur-
gery.12,17 However, we could not identify any difference in
the pain/discomfort domain between types of intervention
at 1 week after the intervention, which is in contrast to
results from a randomized control trial from Denmark,17
which found that bodily pain, physical function, and role
were significantly better in patients who received RFA and
UGFS than surgery at 3 days postoperatively. However, this
apparent advantage was not present at 1 month, suggesting
that RFA and UGFS only had a limited impact on patients.
The utility scores in our study demonstrated significant
improvement at 1 month after treatment and this was more
marked in patients with more severe disease (i.e., CEAP
C3). Utility gain in our study was significantly higher whenres and utility gain between types of intervention.a
UGFS
n Z 23
Surgery
n Z 27
p*
2 (2e4) 2 (2e4) 0.19
0.05 (0.12e0.16) 0.08 (0.12e0.31) 0.16
4 (2e5) 3 (2e5) 0.43
0.19 (0.05e0.39) 0.30 (0.09e0.41) 0.08
rotherapy; VCSS Z Venous Clinical Severity Scores.
ntion.
of life after great saphenous vein ablation in Thai patients with
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CI: 0.197e0.313) versus 0.094 (95% CI: 0.087e0.102);
p < 0.001]. This might be due to increased proportions of
severe spectrum of disease in our studied population (68%
CEAP C3) or treating asymptomatic patients. Unfortunately,
Nesbitt et al9 did not report severity of disease. Never-
theless, caution should be exercised when comparing
health utility gain between different countries because of
different socioeconomic and cultural backgrounds.
With an aging population in Thailand, we can expect to
see more patients with GSV reflux and this will have an
increasing impact on the health care system and health
budget. Therefore, an economic assessment of in-
terventions will be important to determine which in-
terventions are the most cost effective for Thais.18
Our study had some limitations. The total number of
patients was small with some attrition bias (23% at 1
month), causing less power to detect significant difference
of QoL between interventions. In addition, representa-
tiveness of studied patients might be not good. Patients had
selected interventions by themselves based on information
provided by their surgeons. Thus, selection bias could not
be avoided. The QoL analyzed in each domain separately
might inflate the effect of differences with consequent risk
of Type I error. We used only EQ-5D questionnaire, which is
a generic QoL questionnaire that might not capture specific
aspects of venous disease. The reason we chose this ques-
tionnaire is because there is no other validated disease-
specific QoL questionnaire in Thai language. Thus, there is a
need to validate more disease-specific measurement tools
in Thai language.
5. Conclusion
GSV ablation for GSV reflux in Thai patients with CEAP C2
and C3 categories significantly improves both physical and
mental QoL; patients who received endovenous procedures
were found to have better early physical QoL.
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